India took a step forward in its fight against the Covid-19 pandemic on Monday as it began the process of administering the vaccine to citizens. With some help from the Hyderabad-based Bharat Biotech s Covaxin - developed with the help of the Indian Council of Medical Research and National Institute of Virology - and Covishield which was jointly processed by the Oxford University, British-Swedish company AstraZeneca, and manufactured by Serum Institute of India (SII) in Pune, the country found hope as pictures of people taking the shots surfaced. The inoculation drive entered its second phase on Monday in which the coverage was expanded to include everyone above 60 and those over 45 with co-morbidities.